Butterfly Network, Inc. (NYSE: BFLY) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | - | EPS (ttm) | -0.29 | Insider Own | - | Shs Outstand | 266.29M | Perf Week | 7.50% |
| Market Cap | 2.10B | Forward P/E | - | EPS next Y | -0.07 | Insider Trans | -6.29% | Shs Float | 203.13M | Perf Month | -14.07% |
| Enterprise Value | 1.99B | PEG | - | EPS next Q | -0.03 | Inst Own | - | Short Float | 16.77% | Perf Quarter | -11.46% |
| Income | -75.00M | P/S | 18.57 | EPS this Y | 59.48% | Inst Trans | - | Short Ratio | 4.08 | Perf Half Y | 98.49% |
| Sales | 113.00M | P/B | 11.10 | EPS next Y | 36.17% | ROA | -26.45% | Short Interest | 34.06M | Perf YTD | 107.37% |
| Book/sh | 0.71 | P/C | 16.79 | EPS next 5Y | - | ROE | -38.36% | 52W High | 10.05 -21.59% | Perf Year | 383.44% |
| Cash/sh | 0.47 | P/FCF | - | EPS past 3/5Y | - | ROIC | -34.94% | 52W Low | 1.66 374.70% | Perf 3Y | 352.87% |
| Dividend Est. | - | EV/EBITDA | - | Sales past 3/5Y | 10.31% 16.33% | Gross Margin | 52.64% | Volatility | 7.98% 6.73% | Perf 5Y | -38.20% |
| Dividend TTM | - | EV/Sales | 17.63 | EPS Y/Y TTM | 14.71% | Oper. Margin | -70.79% | ATR (14) | 0.59 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.06 | Sales Y/Y TTM | 37.80% | Profit Margin | -66.74% | RSI (14) | 49.67 | Recom | 2.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.06 | EPS Q/Q | 83.33% | SMA20 | -1.12% | Beta | 2.04 | Target Price | 5.19 |
| Payout | 0.00% | Debt/Eq | 0.09 | Sales Q/Q | 43.48% | SMA50 | -1.31% | Rel Volume | 0.76 | Prev Close | 7.96 |
| Employees | 220 | LT Debt/Eq | 0.09 | Earnings | Oct 30 | SMA200 | 46.81% | Avg Volume | 7.23M | Price | 7.88 |
| IPO Date | Jul 13, 2020 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 71.43% 11.84% | Net Debt/EBITDA | 1.59 | Volume | 5,534,355 | Change | -1.00% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Mar-02-26 | Reiterated | Loop Capital Markets | $5.00 → $5.50 | |
| Jan-21-26 | Reiterated | Craig-Hallum | $3.25 → $5.25 | |
| Jan-20-26 | Reiterated | Lake Street | Buy | $5.00 → $5.50 |
| Dec-31-25 | Reiterated | Loop Capital Markets | $5.00 | |
| Aug-04-25 | Reiterated | Craig-Hallum | $3.00 → $2.00 | |
| Jan-10-25 | Reiterated | Lake Street | $3.00 → $5.00 | |
| Nov-29-22 | Reiterated | Oppenheimer | Outperform | $4.50 |
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 113 | 98 | 82 | — | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 52 | 52 | 33 | — | — | — | — | — | — | |
| Gross Profit | 58 | 46 | 49 | — | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 92 | 85 | 85 | — | — | — | — | — | — | |
| Research and Development | 39 | 36 | 38 | — | — | — | — | — | — | |
| Other Operating Expense | 8 | 11 | 0 | — | — | — | — | — | — | |
| Operating Income | -79 | -86 | -74 | — | — | — | — | — | — | |
| Interest Expense | 0 | 1 | 1 | — | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 6 | 11 | 3 | — | — | — | — | — | — | |
| Net Income Before Taxes | -75 | -77 | -73 | — | — | — | — | — | — | |
| Income Taxes | 0 | 0 | 0 | — | — | — | — | — | — | |
| Consolidated Net Income | -75 | -77 | -72 | — | — | — | — | — | — | |
| Net Income From Continuing Operations | -75 | -77 | -72 | — | — | — | — | — | — | |
| Net Income | -75 | -77 | -72 | — | — | — | — | — | — | |
| EPS (Recurring) | -0.29 | -0.31 | -0.34 | — | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | -0.29 | -0.31 | -0.34 | — | — | — | — | — | — | |
| EPS (Diluted) | -0.29 | -0.31 | -0.34 | — | — | — | — | — | — | |
| EBITDA | -67 | -67 | -61 | — | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | — | — | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 18.27 | 9.58 | 8.07 | — | — | — | — | — | — | |
| Gross Margin | 51.33 | 46.94 | 59.76 | — | — | — | — | — | — | |
| Operating Margin | -69.91 | -87.76 | -90.24 | — | — | — | — | — | — | |
| Net Margin | -66.37 | -78.57 | -87.80 | — | — | — | — | — | — | |
| Shares Outstanding | 262 | 247 | 212 | — | — | — | — | — | — | |
| Market Capitalization | 2,065 | 939 | 661 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Carlson Megan | CAO and SVP, Finance | Sep 04 '26 | Sale | 7.30 | 13,804 | 100,797 | 412,085 | Sep 09 |
| Cashman Steve | Chief Business Officer | Sep 04 '26 | Sale | 7.30 | 140,112 | 1,023,098 | 1,490,295 | Sep 09 |
| Caezza Nicholas | Deputy General Counsel | Sep 02 '26 | Sale | 8.15 | 1,709 | 13,927 | 305,166 | Sep 04 |
| ROBBINS LARRY | Director | Aug 17 '26 | Sale | 8.97 | 582,500 | 5,225,142 | 2,964,187 | Aug 17 |
| Phanstiel S. Louise | Director | Aug 14 '26 | Buy | 8.68 | 115,200 | 999,510 | 300,461 | Aug 17 |
| ROBBINS LARRY | Director | Aug 14 '26 | Sale | 8.70 | 824,700 | 7,172,663 | 3,546,687 | Aug 17 |
| ROBBINS LARRY | Director | Aug 13 '26 | Sale | 9.24 | 890,533 | 8,224,688 | 4,371,387 | Aug 17 |
| Caezza Nicholas | Deputy General Counsel | Aug 11 '26 | Sale | 9.75 | 10,000 | 97,500 | 300,307 | Aug 12 |
| DEVIVO JOSEPH | President & CEO | Aug 10 '26 | Sale | 10.01 | 68,346 | 684,075 | 7,603,700 | Aug 12 |
| Carlson Megan | CAO and SVP, Finance | Jul 31 '26 | Sale | 7.86 | 68,852 | 541,383 | 425,889 | Aug 04 |
| ROBBINS LARRY | Director | Aug 03 '26 | Sale | 8.10 | 156,163 | 1,265,670 | 12,458,763 | Aug 03 |
| ROBBINS LARRY | Director | Jul 31 '26 | Sale | 7.39 | 1,720,129 | 12,716,054 | 12,614,926 | Aug 03 |
| ROTHBERG JONATHAN M | Director | Jul 22 '26 | Sale | 6.47 | 36,366 | 235,281 | 0 | Jul 24 |
| ROTHBERG JONATHAN M | director, 10 percent owner: | Jul 21 '26 | Sale | 6.74 | 753,320 | 5,074,288 | 496,680 | Jul 21 |
| DEVIVO JOSEPH | President & CEO | Jul 20 '26 | Sale | 6.56 | 211,798 | 1,389,395 | 7,672,046 | Jul 21 |